INTRODUCTION
Bovine seminal ribonuclease (BS-RNase; EC 3.1.27.5) is an unusual member of the superfamily of secretory ribonucleases. Unlike bovine pancreatic ribonuclease A (RNase A), the prototype of the superfamily with which BS-RNase shares 80% amino acid sequence identity, BS-RNase displays extraordinary biological properties related to cytotoxicity. These properties, which include specific aspermatogenic, anti-tumour, and immunosuppressive activities [1] [2] [3] [4] [5] , give therapeutic potential to BS-RNase [6] . Among these biological properties, immunosuppression is most likely to be of physiological relevance as it may be required to inhibit the immune response of cows against components of bull seminal plasma [7] .
BS-RNase belongs to a family of proteins known as RISBASEs (ribonucleases with special biological action) [8, 9] . RISBASEs come from a variety of species and have diverse biological actions. For example, human angiogenin promotes blood vessel formation [IO] . Onconase from the frog Rana pipiens is a potent anti-tumour agent in phase II human clinical trials in the U.S.A. [11, 12] . S-RNases from plants are responsible for self-incompatibility [13, 14] . The active-site residues in each RISBASE are conserved, and each RISBASE is able to catalyse the cleavage of RNA.
Is the catalytic activity of a RISBASE essential for its special biological action? Mutating the active-site histidine residues makes angiogenin incapable of promoting neovascularization [15] . Chemically modified onconase [12] and eosinophil-derived neurotoxin [16] lose their cytotoxic effects. Still, chemical modification experiments often lead to inconclusive results because the modification is incomplete or perturbs structure rather than function [17] . For example, chemical modification of the catalytic histidine residues in dimeric RNase A (which is similar in form and function to BS-RNase) results in an inactive catalyst that has full anti-tumour activity [18, 19] . Yet, the chemical inactivation of the cleavage of UpA [uridylyl(3'-. 5')adenosine] that were 4 x 103-fold lower. The mutant protein also demonstrated dramatically decreased immunosuppressive, anti-tumour, aspermatogenic, and embryotoxic activities. The catalytic activity of BS-RNase is therefore necessary for its special biological properties.
BS-RNase itself has been reported to result in the loss of its immunosuppressive activity [20] and its anti-tumour activity [21] .
Previously, we reported the efficient expression of a synthetic gene for BS-RNase in Escherichia coli [22] . We have now used this system to prepare a mutant BS-RNase in which His-1 19, an active-site residue, was replaced with an aspartic acid. Here, we report on the consequences of this mutation on the enzymic and biological activities of BS-RNase.
EXPERIMENTAL Materials
Wild-type BS-RNase was purified from bull seminal plasma as described [1, 22] . Recombinant wild-type BS-RNase was also produced in E. coli strain BL21(DE3) by using expression vector pLSRI as described [22] . Plasmid pLSR119 [23] codes for a mutant BS-RNase in which His-119 has been changed to an aspartic acid residue. HI 19D BS-RNase was produced in E. coli strain BL2I(DE3)/pLSRi 19, purified from cellular extract, and folded/oxidized as described [23] . UpA [uridylyl(3' -5')adenosine] was synthesized by J. E. Thompson using the methods of Ogilvie and co-workers [24] and Beaucage and Caruthers [25] . Other materials were obtained as described elsewhere [26] .
Analysis of quaternary structure In dimers of BS-RNase, the subunits are cross-linked by two disulphide bonds between Cys-31 of one subunit and Cys-32 of the other subunit. These cross-linked dimers exist in two distinct quaternary forms, designated as M x M and M = M [27] . In the major form, M x M, the N-terminal tail (residues 1-17) of one subunit stretches out from the C-terminal body of the same subunit and interacts with the body of the other subunit. In the minor form, M = M, this exchange does not occur. The quaternary structure of dimeric Hi 19D BS-RNase (that is, the fraction in the M x M form) was assessed by selective reduction of the two intersubunit disulphide bonds with a 10-fold molar excess of reduced dithiothreitol [28] , and then separation of the resulting non-covalent dimers (which originate from M x M) and monomers (which originate from M = M) by gel-filtration chromatography [26] . The percentage M = M was determined by integration of the gel-filtration profile obtained at 280 nm.
Assay for catalytic activity
The enzyme-catalysed cleavage of UpA was monitored with an adenosine deaminase-coupled assay [29] at 25°C in 0.1 M Mes/HCI buffer, pH 6.0, containing NaCl (0.1 M). The As for this reaction was -6000 M-l cm-' at 265 nm [30] . Protein concentrations were determined by using an absorption coefficient of cO.i% = 0.465 at 278 nm for all forms of BS-RNase [31] and 0°c-= 0.72 at 277.5 nm for RNase A [32] . The values for kcat, Km and keat./Km were determined from initial velocity data with the program HYPERO [33] .
Assays for biological activity Immunosuppressive activity [34] Lymphocytes from the heparinized peripheral blood of two normal allogenic humans were isolated separately on a density gradient (d= 1.077) of Ficoll-Paque solution gradient as described [3] . The cells from the interface were aspirated, washed three times with PBS and resuspended in RPMI 1640 medium containing inactivated pooled human AB serum (20 %, v/v), Lglutamine (2 mM), penicillin (100 units/ml), and streptomycin (50 ,ug/ml). The resulting preparations contained < 98 % mononuclear cells with < 2 % neutrophils or erythrocytes. Cells (1 x I05) from the two preparations were mixed 1: (10 /,g/ml).
RESULTS AND DISCUSSION
HI 19D and wild-type BS-RNase were produced in E. coli and purified to homogeneity. A critical quality of these preparations was the fraction of each dimeric protein that existed in the M x M form. In this form, the N-terminal a-helices of the subunits are exchanged, thereby stabilizing the dimer to conditions that reduce the two intersubunit disulphide bonds. The M x M form appears to be necessary for the special biological actions of BS-RNase, perhaps because it is not bound tightly by cytosolic ribonuclease inhibitor [26] . The fraction of the HI i9D and wild-type BS-RNases from E. coli that were in the M x M form at equilibrium were 60 % and 57 % respectively. Thus any difference in enzymic or biological activity is unlikely to arise from a difference in quaternary structure. BS-RNase, like other ribonucleases, catalyses the transphosphorylation of RNA [36] . During catalysis, the imidazole group of His-1 19 in BS-RNase is likely to serve as a general acid, as does the imidazole group of His-119 of RNase A [37] .
Replacing His-1i19 with an aspartic acid residue in effect tests whether a carboxylic acid group can also serve as a general acid during catalysis.
The steady-state kinetic parameters for UpA cleavage by the wild-type and HI 19D BS-RNases are shown Table 1 . Catalysis by the wild-type enzyme from E. coli and from bull seminal plasma were indistinguishable. Apparently, the additional methionine residue at the N-terminus of the enzyme from E. coli [22] does not side-chain of a particular residue being protonated, then its velocity (v) is given by the proportion: Figure Ia) . Secondly, antitumour activity was assessed with cultures of human tumour cell line K-562. The wild-type BS-RNases showed a strong inhibitory Figure Ib) . Thirdly, we examined the effect of the ribonucleases on spermatogenesis in mice by injecting the ribonucleases into one testis of each of five mice and recording, after 10 days, the diameter of seminiferous tubules, the weight of the testes, and the width of spermatogenic layers. Although wild-type BS-RNase was highly aspermatogenic, neither HI 19D BS-RNase nor RNase A had a significant effect ( Figure Ic) . Finally, the embryotoxicity ofthe ribonucleases was tested by adding the proteins to the medium of cultured bovine embryos and recording mortality. Wild-type BS-RNase was 100 % lethal to bovine embryos 1 day after addition (Figure  ld) . In contrast, RNase A and H119D BS-RNase was only slightly toxic to the embryos 72 h after addition.
In all of the biological assays, wild-type BS-RNase from seminal plasma was slightly more active than was the wild-type protein from E. coli. This result is not unexpected because BSRNase is produced from E. coli in the relatively inactive M = M form [26] . This form largely, but not completely, equilibrates (ti = 1.9 days) with the active M x M form during the time course of the biological assays. (Immunosuppressive activity is assessed after 6 days; anti-tumour activity after 3 days; and aspermatogenic activity after 10 days.) BS-RNase is isolated from seminal plasma as an equilibrium mixture in which 60-80 % of the protein is in the M x M form.
Thus all four biological assays yielded consistent results: HI 19D BS-RNase was biologically inactive. Previous studies used chemically inactivated protein to claim that the catalytic activity of dimeric ribonucleases is either essential for its antitumour and immunosuppressive activities [20, 21] or unimportant for its anti-tumour activity [18, 19] . Here, we have used a BSRNase prepared by site-directed mutagenesis to show that catalytic activity is indeed required for its immunosuppressive and anti-tumour activities, as well as for its aspermatogenic and embryotoxic activities.
